Asian Isothermal Nucleic Acid Amplification Market
- Report Code: IS 1001
- Publish Date: Upcoming
The Nucleic acid amplification technologies are used in the field of molecular biology and recombinant DNA technologies. These techniques are used as the leading methods in detecting and analyzing a small quantity of nucleic acids. Nucleic acid-based testing has been aided by PCR and its variant. However, owing to its stringent requirements in thermo cycling, its use is limited to laboratory settings. This has led to the emergence of a number of novel technologies, collectively termed as the Isothermal Nucleic Acid Amplification Technology (INAAT).
Isothermal Nucleic Acid Amplification has always existed in parallel with PCR; however its market potential was less frequently exploited compared to that of PCR. The Asian region accounted 24.3% market share in 2013. The market value is expected to grow at a CAGR of 17.1% from 2013 to 2018.
Analysis of different market dynamics identifies less expensive molecular testing using INAAT, the increase in prevalence of infectious disease and cancer, rise in demand for enhanced throughput in gene amplification, and advent of novel technologies such as Loop-Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA) and Helicase Dependent Amplification (HDA) are the key driving factors of the market. The growth is attributed to its inherent features such as ease of use, portability, or instrument-free decision.
Asia isothermal nucleic acid amplification market is segmented and forecast on the basis of product segment, technology, major applications and major countries in the Asian region. The market is further segmented and forecasted on the basis of major countries, such as India, China, and Japan.
The report provides an extensive competitive landscaping of companies operating in this market. The key players of the market covered in the report are Hologic Gen-Probe Incorporated, BioMérieux, Becton Diagnostics Segment, BioHelix Corporation, Meridian Bioscience, Inc., Ustar Biotechnologies Ltd., and Novartis AG. This report also includes the market share, value chain analysis, and market metrics such as drivers, restraints and upcoming opportunities in the market.
1 Introduction
1.1 Objective of the Study
1.2 Market Definition and Scope of the Study
1.3 Markets Covered
1.4 Stakeholders
2 Research Methodology
2.1 Integrated ecosystem of Isothermal Nucleic Acid Amplification-Asia
2.2 Arriving at Isothermal Nucleic Acid Amplification-Asia market size
2.2.1 Top down Approach
2.2.2 Bottom-Up Approach
2.2.3 Demand (Consumption) Side Analysis
2.2.4 Macro indicators
2.3 Assumptions
3 Executive Summary
4 Market Overview
4.1 Introduction
4.2 Comparison with Genomics (Parent) Market
4.3 Market Drivers and Inhibitors
4.4 Demand Side Analysis
4.5 Vendor Side Analysis
5 Isothermal Nucleic Acid Amplification-Asia, By Application
5.1 Research Methodology
5.2 Introduction
5.3 Demand Side Analysis
5.4 Vendor Side Analysis
5.5 In Vitro Diagnostics
5.6 Drug Discovery
5.7 Academics
5.8 Agri genomics
5.9 Personalized Medicine
5.10 Other Applications
5.11 Sneak View: Genomics (Parent) Market, By Application
6 Isothermal Nucleic Acid Amplification-Asia, By Product
6.1 Research Methodology
6.2 Introduction
6.3 Comparison with Genomics (Parent) Market
6.4 Vendor Side Analysis
6.5 Isothermal Nucleic Acid Amplification Reagents
6.6 Isothermal Nucleic Acid Amplification Instruments
6.7 Isothermal Nucleic Acid Amplification Services
6.8 Sneak View: Genomics (Parent) Market, By Product
7 Isothermal Nucleic Acid Amplification-Asia, By Technology
7.1 Research Methodology
7.2 Introduction
7.3 Comparison with Genomics (Parent) Market
7.4 Vendor Side Analysis
7.5 Other INAAT Technologies
7.6 Helicase-dependent amplification (HDA)
7.7 Loop-mediated isothermal amplification (LAMP)
7.8 Nucleic acid sequence based amplification (NASBA)
7.9 Transcription-mediated Amplification (TMA)
7.10 Single primer isothermal amplification (SPIA)
7.11 Strand displacement amplification (SDA)
7.12 Sneak View: Genomics (Parent) Market, By Technology
8 Isothermal Nucleic Acid Amplification-Asia, By Geography
8.1 Research Methodology
8.2 Introduction
8.3 Vendor Side Analysis
8.4 Asia - Isothermal Nucleic Acid Amplification Market
8.4.1 Asia - Isothermal Nucleic Acid Amplification Market, By Application
8.4.2 Asia - Isothermal Nucleic Acid Amplification Market, By Product
8.5 Japan Isothermal Nucleic Acid Amplification Market
8.5.1 Japan Isothermal Nucleic Acid Amplification Market, By Application
8.5.2 Japan Isothermal Nucleic Acid Amplification Market, By Product
8.6 China Isothermal Nucleic Acid Amplification Market
8.6.1 China Isothermal Nucleic Acid Amplification Market, By Application
8.7.2 China Isothermal Nucleic Acid Amplification Market, By Product
8.8 India Isothermal Nucleic Acid Amplification Market
8.8.1 India Isothermal Nucleic Acid Amplification Market, By Application
8.8.2 India Isothermal Nucleic Acid Amplification Market, By Product
8.9 Asia - Other Geographies Isothermal Nucleic Acid Amplification Market
8.9.1 Asia - Other Geographies Isothermal Nucleic Acid Amplification Market, By Application
8.9.2 Asia - Other Geographies Isothermal Nucleic Acid Amplification Market, By Product
8.10 Sneak View: Genomics (Parent) Market, By Geography
9 Competitive Landscape
9.1 Competitive Landscape
9.1.1 Merger & Acquisition
9.1.2 Other Expansion
9.1.3 New Synergies
10 Isothermal Nucleic Acid Amplification-Asia, By Company
10.1 Becton Diagnostics Segment
10.1.1 Revenue Mix for 2013
10.1.2 Historical Revenue Data
10.1.3 Product and Service Offerings
10.1.4 Key Developments
10.1.5 MMM Analysis
10.2 BioHelix Corporation
10.2.1 Revenue Mix for 2013
10.2.2 Historical Revenue Data
10.2.3 Product and Service Offerings
10.2.4 Key Developments
10.2.5 MMM Analysis
10.3 BioMérieux
10.3.1 Revenue Mix for 2013
10.3.2 Historical Data
10.3.3 Product and Service Offerings
10.3.4 Key Developments
10.3.5 MMM Analysis
10.4 Hologic Gen-Probe Incorporated
10.4.1 Revenue Mix for 2013
10.4.2 Historical Data
10.4.4 Product and Service Offerings
10.4.5 Key Developments
10.4.6 MMM Analysis
10.5 F. Meridian Bioscience, Inc.
10.5.1 Revenue Mix for 2013
10.5.2 Historical Data
10.5.3 Product and Service Offerings
10.5.4 Key Developments
10.5.5 MMM Analysis
10.6 Novartis AG
10.6.1 Revenue Mix for 2013
10.6.2 Historical Data
10.6.3 Product and Service Offerings
10.6.4 Key Developments
10.6.5 MMM Analysis
10.6 Ustar Biotechnologies Ltd.
10.6.1 Revenue Mix for 2013
10.6.2 Historical Data
10.6.3 Product and Service Offerings
10.6.4 Key Developments
10.6.5 MMM Analysis
11 APPENDIX
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
